Media – Active Biotech

Press Contact

For press and communication related matters regarding our company, business or projects, please contact:

Helén Tuvesson
President & CEO
+46 46 19 21 56helen.tuvesson@activebiotech.com
Hans Kolam
Chief Financial Officer
+46 46 19 20 44hans.kolam@activebiotech.com

Press Releases

Press Release
Active Biotech Interim Report Q2 2026
2026-08-20
Regulatory
Press Release
Active Biotech expands US collaboration to advance tasquinimod clinical development in myelofibrosis
2026-08-18
Press Release
First patient dosed in the amended HO172 clinical study of tasquinimod in myelofibrosis
2026-07-24
Press Release
Number of shares and votes in Active Biotech
2026-06-30
Regulatory
Press Release
Active Biotech announces timetable for reverse share split
2026-05-28
Regulatory
Press Release
Annual General Meeting of Active Biotech AB
2026-05-20
Regulatory

See all press releases